Shaozhen Xie, Ph.D. - Publications

Affiliations: 
2007 University of Rochester, Rochester, NY 
Area:
Molecular Biology

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Liu Z, Wang Y, Kabraji S, Xie S, Pan P, Liu Z, Ni J, Zhao JJ. Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid injection method. Scientific Reports. 9: 622. PMID 30679540 DOI: 10.1038/s41598-018-36874-3  0.68
2018 Kabraji S, Ni J, Lin N, Xie S, Winer EP, Zhao JJ. Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29437794 DOI: 10.1158/1078-0432.CCR-17-3351  0.68
2016 Cizmecioglu O, Ni J, Xie S, Zhao JJ, Roberts TM. Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss. Elife. 5. PMID 27700986 DOI: 10.7554/eLife.17635  0.68
2016 Ni J, Xie S, Ramkissoon SH, Luu V, Sun Y, Bandopadhayay P, Beroukhim R, Roberts TM, Stiles CD, Segal RA, Ligon KL, Hahn WC, Zhao JJ. Tyrosine receptor kinase B is a drug target in astrocytomas. Neuro-Oncology. PMID 27402815 DOI: 10.1093/neuonc/now139  0.68
2016 Fan W, Xie S, Zhao X, Li N, Chang C, Li L, Yu G, Chi X, Pan Y, Niu J, Zhong J, Sun B. IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18. The Journal of General Virology. PMID 27302182 DOI: 10.1099/jgv.0.000522  0.68
2016 Ni J, Ramkissoon SH, Xie S, Goel S, Stover DG, Guo H, Luu V, Marco E, Ramkissoon LA, Kang YJ, Hayashi M, Nguyen QD, Ligon AH, Du R, Claus EB, et al. Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases. Nature Medicine. PMID 27270588 DOI: 10.1038/nm.4120  0.68
2015 Luo W, Chen Y, Wang T, Hong C, Chang LP, Chang CC, Yang YC, Xie SQ, Wang CJ. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities. Bioorganic & Medicinal Chemistry. PMID 26752094 DOI: 10.1016/j.bmc.2015.12.031  0.44
2012 Gao T, Gao Y, Chang C, Chen Y, Liu M, Xie S, He K, Ma X, Zhang Y, Liu Z. Atomic-scale morphology and electronic structure of manganese atomic layers underneath epitaxial graphene on SiC(0001). Acs Nano. 6: 6562-8. PMID 22861188 DOI: 10.1021/nn302303n  0.68
2012 Ni J, Liu Q, Xie S, Carlson C, Von T, Vogel K, Riddle S, Benes C, Eck M, Roberts T, Gray N, Zhao J. Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anticancer agent. Cancer Discovery. 2: 425-33. PMID 22588880 DOI: 10.1158/2159-8290.CD-12-0003  0.52
2011 Xie S, Ni J, Lee YF, Liu S, Li G, Shyr CR, Chang C. Increased acetylation in the DNA-binding domain of TR4 nuclear receptor by the coregulator ARA55 leads to suppression of TR4 transactivation. The Journal of Biological Chemistry. 286: 21129-36. PMID 21515881 DOI: 10.1074/jbc.M110.208181  0.68
2009 Xie S, Lee YF, Kim E, Chen LM, Ni J, Fang LY, Liu S, Lin SJ, Abe J, Berk B, Ho FM, Chang C. TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation. Proceedings of the National Academy of Sciences of the United States of America. 106: 13353-8. PMID 19666541 DOI: 10.1073/pnas.0905724106  0.68
2009 Ni J, Mai T, Pang ST, Haque I, Huang K, DiMaggio MA, Xie S, James NS, Kasi D, Chemler SR, Yeh S. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 898-906. PMID 19188160 DOI: 10.1158/1078-0432.CCR-08-1087  0.52
2008 Li G, Lee YF, Liu S, Cai Y, Xie S, Liu NC, Bao BY, Chen Z, Chang C. Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a. Endocrinology. 149: 3490-9. PMID 18388194 DOI: 10.1210/en.2008-0121  0.52
2008 Chen LM, Wang RS, Lee YF, Liu NC, Chang YJ, Wu CC, Xie S, Hung YC, Chang C. Subfertility with defective folliculogenesis in female mice lacking testicular orphan nuclear receptor 4. Molecular Endocrinology (Baltimore, Md.). 22: 858-67. PMID 18174360 DOI: 10.1210/me.2007-0181  0.52
2007 Shi W, Chang C, Nie S, Xie S, Wan M, Cao X. Endofin acts as a Smad anchor for receptor activation in BMP signaling. Journal of Cell Science. 120: 1216-24. PMID 17356069 DOI: 10.1242/jcs.03400  0.68
2007 Zhang Y, Chen YT, Xie S, Wang L, Lee YF, Chang SS, Chang C. Loss of testicular orphan receptor 4 impairs normal myelination in mouse forebrain. Molecular Endocrinology (Baltimore, Md.). 21: 908-20. PMID 17227886 DOI: 10.1210/me.2006-0219  0.68
2005 Ni J, Wen X, Yao J, Chang HC, Yin Y, Zhang M, Xie S, Chen M, Simons B, Chang P, di Sant'Agnese A, Messing EM, Yeh S. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Research. 65: 9807-16. PMID 16267002 DOI: 10.1158/0008-5472.CAN-05-1334  0.68
2005 Yang L, Xie S, Jamaluddin MS, Altuwaijri S, Ni J, Kim E, Chen YT, Hu YC, Wang L, Chuang KH, Wu CT, Chang C. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. The Journal of Biological Chemistry. 280: 33558-65. PMID 16061480 DOI: 10.1074/jbc.M504461200  0.68
2004 Wang L, Lin HK, Hu YC, Xie S, Yang L, Chang C. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells. The Journal of Biological Chemistry. 279: 32444-52. PMID 15178691 DOI: 10.1074/jbc.M313963200  0.68
2004 Xie S, Lin HK, Ni J, Yang L, Wang L, di Sant'Agnese PA, Chang C. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells. The Prostate. 60: 61-7. PMID 15129430 DOI: 10.1002/pros.20048  0.68
2004 Yang L, Yeh SD, Xie S, Altuwaijri S, Ni J, Hu YC, Chen YT, Bao BY, Su CH, Chang C. Androgen suppresses PML protein expression in prostate cancer CWR22R cells. Biochemical and Biophysical Research Communications. 314: 69-75. PMID 14715247  0.68
2003 Kim E, Xie S, Yeh SD, Lee YF, Collins LL, Hu YC, Shyr CR, Mu XM, Liu NC, Chen YT, Wang PH, Chang C. Disruption of TR4 orphan nuclear receptor reduces the expression of liver apolipoprotein E/C-I/C-II gene cluster. The Journal of Biological Chemistry. 278: 46919-26. PMID 12954636 DOI: 10.1074/jbc.M304088200  0.52
2003 Yang L, Wang L, Lin HK, Kan PY, Xie S, Tsai MY, Wang PH, Chen YT, Chang C. Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells. Biochemical and Biophysical Research Communications. 305: 462-9. PMID 12763015  0.68
2003 Yang L, Lin HK, Altuwaijri S, Xie S, Wang L, Chang C. APPL suppresses androgen receptor transactivation via potentiating Akt activity. The Journal of Biological Chemistry. 278: 16820-7. PMID 12621049 DOI: 10.1074/jbc.M213163200  0.68
Show low-probability matches.